Canagliflozin and Stroke in Type 2 Diabetes Mellitus: Results From the Randomized CANVAS Program Trials

BACKGROUND AND PURPOSE—: This study reports the detailed effects of canagliflozin on stroke, stroke subtypes, and vascular outcomes in participants with and without cerebrovascular disease (stroke or transient ischemic attack) at baseline from the CANVAS (Canagliflozin Cardiovascular Assessment Stud...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Stroke
Hlavní autoři: Zhou, Zien, Lindley, Richard I., Rådholm, Karin, Jenkins, Bronwyn, Watson, John, Perkovic, Vlado, Mahaffey, Kenneth W., de Zeeuw, Dick, Fulcher, Greg, Shaw, Wayne, Oh, Richard, Desai, Mehul, Matthews, David R., Neal, Bruce
Médium: Artigo
Jazyk:Inglês
Vydáno: Lippincott Williams & Wilkins 2019
Témata:
Original Contributions
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6358191/
https://ncbi.nlm.nih.gov/pubmed/30591006
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.118.023009
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky